1. Home
  2. GNSS vs NSPR Comparison

GNSS vs NSPR Comparison

Compare GNSS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$1.89

Market Cap

84.1M

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.26

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
NSPR
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.1M
72.1M
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
GNSS
NSPR
Price
$1.89
$1.26
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$4.75
$4.00
AVG Volume (30 Days)
96.8K
47.9K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
N/A
EPS
N/A
N/A
Revenue
$26,306,790.00
$2,310,000.00
Revenue This Year
$80.08
$57.98
Revenue Next Year
N/A
$95.41
P/E Ratio
N/A
N/A
Revenue Growth
29.50
N/A
52 Week Low
$1.40
$1.19
52 Week High
$2.70
$2.93

Technical Indicators

Market Signals
Indicator
GNSS
NSPR
Relative Strength Index (RSI) 52.95 23.23
Support Level $1.87 N/A
Resistance Level $2.05 $2.47
Average True Range (ATR) 0.08 0.09
MACD 0.00 -0.01
Stochastic Oscillator 41.68 5.33

Price Performance

Historical Comparison
GNSS
NSPR

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: